{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:40:58Z","timestamp":1776746458708,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T00:00:00Z","timestamp":1688256000000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI119090"],"award-info":[{"award-number":["R01 AI119090"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.nano.2022.102579","type":"journal-article","created":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T17:07:02Z","timestamp":1656263222000},"page":"102579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Polymeric dexamethasone prodrugs attenuate lupus nephritis in MRL\/lpr mice with reduced glucocorticoid toxicity"],"prefix":"10.1016","volume":"44","author":[{"given":"Zhifeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haochen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenshan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongguo","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk W.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Goldring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Crow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2022.102579_bb0005","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2022.102579_bb0010","first-page":"330","article-title":"Manifestations of systemic lupus erythematosus","volume":"6","author":"Cojocaru","year":"2011","journal-title":"Maedica (Bucur)"},{"key":"10.1016\/j.nano.2022.102579_bb0015","doi-asserted-by":"crossref","first-page":"ITC81","DOI":"10.7326\/AITC202006020","article-title":"Systemic lupus erythematosus","volume":"172","author":"Kiriakidou","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nano.2022.102579_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12969-019-0349-y","article-title":"Whole exome sequencing in childhood-onset lupus frequently detects single gene etiologies","volume":"17","author":"Tirosh","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.nano.2022.102579_bb0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nano.2022.102579_bb0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","article-title":"What is damaging the kidney in lupus nephritis?","volume":"12","author":"Davidson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.nano.2022.102579_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mce.2007.05.019","article-title":"Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists","volume":"275","author":"Stahn","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.nano.2022.102579_bb0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.nano.2022.102579_bb0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fendo.2017.00016","article-title":"New insights in glucocorticoid receptor signaling-more than just a ligand-binding receptor","volume":"8","author":"Scheschowitsch","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.nano.2022.102579_bb0050","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1007\/s11095-008-9683-3","article-title":"Synthesis and evaluation of a well-defined HPMA copolymer-dexamethasone conjugate for effective treatment of rheumatoid arthritis","volume":"25","author":"Liu","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2022.102579_bb0055","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1002\/art.34667","article-title":"Dexamethasone prodrug treatment prevents nephritis in lupus-prone (NZB x NZW)F1 mice without causing systemic side effects","volume":"64","author":"Yuan","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nano.2022.102579_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081483","article-title":"A dexamethasone prodrug reduces the renal macrophage response and provides enhanced resolution of established murine lupus nephritis","volume":"8","author":"Yuan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2022.102579_bb0065","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1021\/acsnano.8b01249","article-title":"Micelle-forming dexamethasone prodrug attenuates nephritis in lupus-prone mice without apparent glucocorticoid side effects","volume":"12","author":"Jia","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2022.102579_bb0070","article-title":"Dexamethasone prodrug nanomedicine (ZSJ-0228) treatment significantly reduces lupus nephritis in mice without measurable side effects - a 5-month study","volume":"102302","author":"Zhao","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2022.102579_bb0075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneph.2015.33","article-title":"Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis","volume":"11","author":"Mohan","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nano.2022.102579_bb0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.2003.tb06033.x","article-title":"Intrinsic T cell defects in systemic autoimmunity","volume":"987","author":"Kong","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nano.2022.102579_bb0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35100573","article-title":"From T to B and back again: positive feedback in systemic autoimmune disease","volume":"1","author":"Shlomchik","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2022.102579_bb0090","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm.2752","article-title":"Taming lupus-a new understanding of pathogenesis is leading to clinical advances","volume":"18","author":"Liu","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2022.102579_bb0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/BOR.0000000000000412","article-title":"An update on lupus animal models","volume":"29","author":"Li","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.nano.2022.102579_bb0100","article-title":"Murine models of systemic lupus erythematosus","volume":"2011","author":"Perry","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.nano.2022.102579_bb0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.iy.09.040191.001331","article-title":"Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease","volume":"9","author":"Cohen","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nano.2022.102579_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/laban1005-39","article-title":"A rapid, simple, and humane method for submandibular bleeding of mice using a lancet","volume":"34","author":"Golde","year":"2005","journal-title":"Lab Anim (NY)"},{"key":"10.1016\/j.nano.2022.102579_bb0115","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/art.27452","article-title":"Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice","volume":"62","author":"Deng","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nano.2022.102579_bb0120","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.4049\/jimmunol.171.8.4439","article-title":"Repeated alpha-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr\/lpr mice","volume":"171","author":"Yang","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2022.102579_bb0125","doi-asserted-by":"crossref","first-page":"6047085","DOI":"10.1155\/2019\/6047085","article-title":"Detection by flow cytometry of anti-DNA autoantibodies and circulating DNA immune complexes in lupus erythematosus","volume":"2019","author":"Abuaf","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.nano.2022.102579_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236021","article-title":"Multiple functions of B cells in the pathogenesis of systemic lupus erythematosus","volume":"20","author":"Ma","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2022.102579_bb0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/art.21556","article-title":"Prevention and reversal of nephritis in MRL\/lpr mice with a single injection of C-reactive protein","volume":"54","author":"Rodriguez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nano.2022.102579_bb0140","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.180.2.1231","article-title":"Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL\/lpr mice","volume":"180","author":"Atkinson","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2022.102579_bb0145","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1073\/pnas.2000943117","article-title":"Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis","volume":"117","author":"Jing","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2022.102579_bb0150","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.4049\/jimmunol.133.4.1955","article-title":"Studies of lymphoproliferation in MRL-lpr\/lpr mice","volume":"133","author":"Smathers","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2022.102579_bb0155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.gene.6364286","article-title":"Genomic view of systemic autoimmunity in MRLlpr mice","volume":"7","author":"Liu","year":"2006","journal-title":"Genes Immun"},{"key":"10.1016\/j.nano.2022.102579_bb0160","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.4049\/jimmunol.1102859","article-title":"Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival","volume":"188","author":"Mannoor","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2022.102579_bb0165","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejim.2013.05.014","article-title":"Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself","volume":"24","author":"Dinsen","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.nano.2022.102579_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2019-000569","article-title":"Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children","volume":"3","author":"Ahmet","year":"2019","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/j.nano.2022.102579_bb0175","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1021\/acs.molpharmaceut.1c00567","article-title":"Preclinical dose-escalation study of ZSJ-0228, a polymeric dexamethasone prodrug, in the treatment of murine lupus nephritis","volume":"18","author":"Zhao","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2022.102579_bb0180","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.nano.2022.102579_bb0185","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","article-title":"Glucocorticoid receptor signaling in health and disease","volume":"34","author":"Kadmiel","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nano.2022.102579_bb0190","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semnephrol.2015.08.002","article-title":"Genetics of lupus nephritis: clinical implications","volume":"35","author":"Munroe","year":"2015","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.nano.2022.102579_bb0195","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11926-011-0180-z","article-title":"Treatment of cutaneous lupus","volume":"13","author":"Chang","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.nano.2022.102579_bb0200","article-title":"Head-to-head comparative pharmacokinetic and biodistribution (PK\/BD) study of two dexamethasone prodrug nanomedicines on lupus-prone NZB\/WF1 mice","volume":"29","author":"Wei","year":"2020","journal-title":"Nanomedicine"},{"issue":"Suppl 4","key":"10.1016\/j.nano.2022.102579_bb0205","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar3919","article-title":"Unmet medical needs in systemic lupus erythematosus","volume":"14","author":"Lateef","year":"2012","journal-title":"Arthritis Res Ther"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996342200065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154996342200065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:17:20Z","timestamp":1761549440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154996342200065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":41,"alternative-id":["S154996342200065X"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2022.102579","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric dexamethasone prodrugs attenuate lupus nephritis in MRL\/lpr mice with reduced glucocorticoid toxicity","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2022.102579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102579"}}